| Year |
Citation |
Score |
| 2013 |
Segovia KN, Vontell R, López-Cruz L, Salamone JD, Correa M. c-Fos immunoreactivity in prefrontal, basal ganglia and limbic areas of the rat brain after central and peripheral administration of ethanol and its metabolite acetaldehyde. Frontiers in Behavioral Neuroscience. 7: 48. PMID 23745109 DOI: 10.3389/Fnbeh.2013.00048 |
0.595 |
|
| 2012 |
Segovia KN, Correa M, Lennington JB, Conover JC, Salamone JD. Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. The European Journal of Neuroscience. 35: 1354-67. PMID 22462413 DOI: 10.1111/J.1460-9568.2012.08036.X |
0.576 |
|
| 2012 |
Correa M, Salamone JD, Segovia KN, Pardo M, Longoni R, Spina L, Peana AT, Vinci S, Acquas E. Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neuroscience and Biobehavioral Reviews. 36: 404-30. PMID 21824493 DOI: 10.1016/J.Neubiorev.2011.07.009 |
0.471 |
|
| 2011 |
Segovia KN, Correa M, Salamone JD. Slow phasic changes in nucleus accumbens dopamine release during fixed ratio acquisition: a microdialysis study. Neuroscience. 196: 178-88. PMID 21884757 DOI: 10.1016/J.Neuroscience.2011.07.078 |
0.617 |
|
| 2010 |
Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacology, Biochemistry, and Behavior. 97: 179-84. PMID 20713079 DOI: 10.1016/J.Pbb.2010.07.021 |
0.61 |
|
| 2010 |
Sink KS, Segovia KN, Collins LE, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacology, Biochemistry, and Behavior. 95: 479-84. PMID 20347865 DOI: 10.1016/J.Pbb.2010.03.011 |
0.613 |
|
| 2010 |
Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience. 166: 1056-67. PMID 20096336 DOI: 10.1016/J.Neuroscience.2009.12.056 |
0.699 |
|
| 2010 |
Sink KS, Segovia KN, Sink J, Randall PA, Collins LE, Correa M, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 112-22. PMID 20015619 DOI: 10.1016/J.Euroneuro.2009.11.002 |
0.734 |
|
| 2010 |
Vontell R, Segovia KN, Betz AJ, Mingote S, Goldring K, Cartun RW, Salamone JD. Immunocytochemistry studies of basal ganglia adenosine A2A receptors in rat and human tissue Journal of Histotechnology. 33: 41-47. DOI: 10.1179/His.2010.33.1.41 |
0.643 |
|
| 2009 |
Sink KS, Segovia KN, Nunes EJ, Collins LE, Vemuri VK, Thakur G, Makriyannis A, Salamone JD. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology. 206: 223-32. PMID 19588124 DOI: 10.1007/S00213-009-1602-8 |
0.707 |
|
| Show low-probability matches. |